You can buy or sell HZNP and other stocks, options, ETFs, and crypto commission-free!
Horizon Therapeutics Public Limited Company Ordinary Shares, also called Horizon Therapeutics, is a biopharmaceutical company which is engaged in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. Read More It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. The company was founded in 2008 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
Yahoo FinanceMay 16
Horizon Therapeutics plc Launches New Data-Driven Campaign to Reset the Dialogue on Gout
DUBLIN--(BUSINESS WIRE)-- -- Research that has redefined the trajectory and true impact of the disease underscores the campaign -- Horizon Therapeutics plc (HZNP) today announced the launch of Gout Lies, a data-driven campaign to reframe physician dialogue on the reality of living with gout and underscore findings of recent research that warrant a new view on how to properly manage the disease. Scroll to continue with content Ad Through a mix of thought-provoking visuals, expert videos and clinical data...
Yahoo FinanceMay 9
Horizon Therapeutics' Q1 Earnings Beat Estimates
Horizon Therapeutics plc HZNP, previously known as Horizon Pharma plc, reported first-quarter adjusted earnings of 30 cents per share, which beat the Zacks Consensus Estimate of 10 cents and increased from 3 cents reported in the year-ago quarter.
Expected Aug 7, Pre-Market